-
Mashup Score: 7Dosimetric analysis of 17 cardiac Sub-structures, Toxicity, and survival in ultra central lung tumor patients treated with SBRT - 6 month(s) ago
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: PMC Disclaimer | PMC Copyright
Source: www.ncbi.nlm.nih.govCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 0ராயப்பேட்டை அரசு மருத்துவமனையில் உயர்தர சிகிச்சை | Liposarcoma | Rare cancer | cancerawareness - 6 month(s) ago
வயிற்றில் 8 கிலோ கட்டி !நூதன ஆபரேஷனால் உயிர் பிழைத்த நோயாளி#Liposarcoma #Rarecancer #cancerawareness
Source: www.youtube.comCategories: Latest Headlines, Oncologists2Tweet-
Fighting against #cancer https://t.co/cxBGsX5jKb @ROGAGRH
-
-
Mashup Score: 0El Roto - 6 month(s) ago
Viñeta de El Roto del 18 de octubre de 2023
Source: elpais.comCategories: Latest Headlines, Oncologists2Tweet-
El Roto https://t.co/xEK22iPPu1 vía @el_pais
-
-
Mashup Score: 6Tumor Board Tuesday 2023 Conversations - 6 month(s) ago
Tumor Board Tuesdays is a regularly scheduled, Twitter-based case discussion forum led by expert faculty exploring cases in various solid tumor malignancies. The series will focus on practice application in the clinic. Experts will present recent data and focus on realistic case examples. The advantage to this format is the ability to comment and receive feedback from the experts.
Source: integrityce.comCategories: Latest Headlines, Oncologists2Tweet-
RT @TumorBoardTues: #PreTest Q1️⃣ #TumorBoardTuesday Free #CME https://t.co/Gzqzvik9BR ➡️B4 @AmandaNizamMD & @YuWeiChenMD🗣️Tx for #rcc aft…
-
-
Mashup Score: 3
In treatment-naive patients, nivolumab induction with or without nivolumab plus ipilimumab boosts significantly improved the objective response rate compared with that reported for nivolumab monotherapy in the CheckMate-025 trial. However, overall efficacy seemed inferior when compared with approved upfront nivolumab plus ipilimumab. For second-line treatment, nivolumab plus ipilimumab could be a rescue strategy on progression with approved nivolumab monotherapy.
Source: www.thelancet.comCategories: Latest Headlines, Oncologists2Tweet-
Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial - The Lancet Oncology https://t.co/xwY44Ei6c9
-
-
Mashup Score: 3Summary - The 3 E’s of ICI in Endometrial Cancer: Emergence, Evolution, and Expansion - 6 month(s) ago
ABOUT EVENTGSK welcomes gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other clinicians who treat patients with gynecologic malignancies to register for the The 3 E’s of ICI in Endometrial Cancer: Emergence, Evolution, and Expansion, an Industry Supported Symposium at the IGCS 2023 Global Annual Meeting. This in person and virtual education session will be held…
Source: web.cvent.comCategories: Latest Headlines, Oncologists2Tweet-
RT @IGCSociety: Attending #IGCS2023? Go to https://t.co/VcA2JDMgRn to register for this Industry Supported Symposia. #clinicaltrials #Gynec…
-
-
Mashup Score: 1Chopin - Variation 6 From Hexameron - 6 month(s) ago
This is Chopin’s contribution to Hexameron, a set of variations on a theme from Bellini’s opera I Puritani. Several different composers each wrote a variation on the theme and these were assembled int
Source: soundcloud.comCategories: Latest Headlines, Oncologists2Tweet-
Here is one of his least-known compositions, his contribution to Hexaméron, a compilation of variations on a theme from Bellini's opera I Puritani by himself and Liszt, Thalberg, Pixis, Herz, and Czerny. https://t.co/GVnHI2NpUo https://t.co/jYQ6mKRzVJ
-
-
Mashup Score: 34
Bagha Jatin (2023), Action Drama Historical released in Bengali language in theatre near you. Know about Film reviews, lead cast & crew, photos & video gallery on BookMyShow.
Source: in.bookmyshow.comCategories: Latest Headlines, Oncologists2Tweet-
RT @idevadhikari: The wait is almost over - 2 Days To Go! In Cinemas from 19th October. Book your tickets now! https://t.co/nXnAc0hk6a ht…
-
-
Mashup Score: 0BIR Publications - 6 month(s) ago
Abstract This machine was the first linear accelerator designed for medical use and the first to be installed in a hospital. The first patient was treated in 1953 and the last in 1969. During this period the machine was used for research during the evenings and latterly it was available for research all day long. It was switched off for the last time in February 1984. In addition to the X-ray beam, electrons were used for treatment and for research, where the high dose rate and large field size were particularly useful. An account is given of some of the highlights of the clinical and research programmes.
Source: www.birpublications.orgCategories: Latest Headlines, Oncologists2Tweet-
@alison_tree Reference is here: https://t.co/2bFwmpyQYy
-
-
Mashup Score: 1BMJ Careers hiring Cellular Pathologist/Histopathologist with interest Gynaecological in London, England, United Kingdom | LinkedIn - 6 month(s) ago
Posted 7:22:26 AM. Consultant Cellular Pathologist / Histopathologist Full Time 10 PA, Substantive Appointment in…See this and similar jobs on LinkedIn.
Source: www.linkedin.comCategories: Latest Headlines, Oncologists2Tweet-
RT @daniel_berney: Gynae path job at @NHSBartsHealth Check out this job from BMJ Careers https://t.co/ybdWTmEjRA
-
Dosimetric analysis of 17 cardiac Sub-structures, Toxicity, and survival in ultra central lung tumor patients treated with SBRT. #radonc https://t.co/tAM7HB1GdB https://t.co/w8uHsumzum